Home > Healthcare > Medical Devices > Implantable Devices > iliac stents market
Get a free sample of Iliac Stents Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Iliac Stents Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The iliac stents industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy.
Some of the eminent market participants operating in the iliac stents industry include:
The balloon-expandable iliac segment and is expected to register 5.2% CAGR from 2024-2032 due to their familiarity with the deployment technique and perceived ease of use compared to other type of stents.
Iliac stents market size was USD 899.9 million in 2023 and is expected to register 5% CAGR from 2024-2032 owing to the increasing prevalence of peripheral artery disease (PAD) worldwide.
North America iliac stents industry reached USD 216.8 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to increasing awareness among patients and healthcare providers about vascular diseases and available treatment options in the region.
Abbott Laboratories, Alvimedica, Becton, Dickinson and Company, Biotronik, Boston Scientific Corporation, B. Braun SE, Cook, Getinge AB, iVascular, and Medtronic Plc, are some of the major iliac stents companies worldwide.